Outcome of pneumonectomy for primary non-small cell lung cancer - A ten-year experience

N. Y. Hsu, C. Y. Chen, C. P. Hsu

Research output: Contribution to journalArticle

Abstract

Between 1982 and 1992, 105 patients with non-small cell lung cancer underwent pneumonectomy and mediastinal node dissection. Thirteen patients (12%) were categorized as pathological stage I, 18 (17%) were categorized as pathological stage II, 63 (60%) were categorized as pathological stage IIIa, and 11 (11%) were categorized as pathological stage IIIb. The overall actuarial 3-year survival rate was 27%. Postpneumonectomy complications occurred in 20 patients. Operative mortality occurred only in 8 pathological stage IIIa male patients (7.6%). No significant differences in operative mortality were noted for the following criteria: age, sex, side of resection, pathological stage, histologic classification, preoperative forced expiratory volume in 1 second (FEV1) of 2.0 L or less, and predicted postoperative FEV1 of 1.0 L or less. Of the surviving 97 patients, 3 patients were lost during follow-up, 13 patients (13.8%) died due to pneumonia and/or respiratory failure, and 40 patients (42.6%) died due to distant metastases, with bone as the most common metastatic site, during the mean follow-up time of 39 months. Pathological stage I and stage II patients showed actuarial 3-year survival rates, of 60.0% and 31.3% respectively. The survival rates of stage I and stage II patients were higher than for stage IIIa patients.

Original languageEnglish
Pages (from-to)19-24
Number of pages6
JournalRadiology and Oncology
Volume29
Issue number1
Publication statusPublished - 1995
Externally publishedYes

Fingerprint

Pneumonectomy
Non-Small Cell Lung Carcinoma
Survival Rate
Forced Expiratory Volume
Mortality
Respiratory Insufficiency
Dissection
Pneumonia
Neoplasm Metastasis
Bone and Bones

Keywords

  • carcinoma non-small-cell lung
  • lung neoplasms-surgery
  • pneumonectomy
  • survival rate

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

Outcome of pneumonectomy for primary non-small cell lung cancer - A ten-year experience. / Hsu, N. Y.; Chen, C. Y.; Hsu, C. P.

In: Radiology and Oncology, Vol. 29, No. 1, 1995, p. 19-24.

Research output: Contribution to journalArticle

Hsu, N. Y. ; Chen, C. Y. ; Hsu, C. P. / Outcome of pneumonectomy for primary non-small cell lung cancer - A ten-year experience. In: Radiology and Oncology. 1995 ; Vol. 29, No. 1. pp. 19-24.
@article{b79b842ef4f541d5a905896b07fcc781,
title = "Outcome of pneumonectomy for primary non-small cell lung cancer - A ten-year experience",
abstract = "Between 1982 and 1992, 105 patients with non-small cell lung cancer underwent pneumonectomy and mediastinal node dissection. Thirteen patients (12{\%}) were categorized as pathological stage I, 18 (17{\%}) were categorized as pathological stage II, 63 (60{\%}) were categorized as pathological stage IIIa, and 11 (11{\%}) were categorized as pathological stage IIIb. The overall actuarial 3-year survival rate was 27{\%}. Postpneumonectomy complications occurred in 20 patients. Operative mortality occurred only in 8 pathological stage IIIa male patients (7.6{\%}). No significant differences in operative mortality were noted for the following criteria: age, sex, side of resection, pathological stage, histologic classification, preoperative forced expiratory volume in 1 second (FEV1) of 2.0 L or less, and predicted postoperative FEV1 of 1.0 L or less. Of the surviving 97 patients, 3 patients were lost during follow-up, 13 patients (13.8{\%}) died due to pneumonia and/or respiratory failure, and 40 patients (42.6{\%}) died due to distant metastases, with bone as the most common metastatic site, during the mean follow-up time of 39 months. Pathological stage I and stage II patients showed actuarial 3-year survival rates, of 60.0{\%} and 31.3{\%} respectively. The survival rates of stage I and stage II patients were higher than for stage IIIa patients.",
keywords = "carcinoma non-small-cell lung, lung neoplasms-surgery, pneumonectomy, survival rate",
author = "Hsu, {N. Y.} and Chen, {C. Y.} and Hsu, {C. P.}",
year = "1995",
language = "English",
volume = "29",
pages = "19--24",
journal = "Radiology and Oncology",
issn = "1318-2099",
publisher = "Slovenian Medical Society / Croatian Medical Association",
number = "1",

}

TY - JOUR

T1 - Outcome of pneumonectomy for primary non-small cell lung cancer - A ten-year experience

AU - Hsu, N. Y.

AU - Chen, C. Y.

AU - Hsu, C. P.

PY - 1995

Y1 - 1995

N2 - Between 1982 and 1992, 105 patients with non-small cell lung cancer underwent pneumonectomy and mediastinal node dissection. Thirteen patients (12%) were categorized as pathological stage I, 18 (17%) were categorized as pathological stage II, 63 (60%) were categorized as pathological stage IIIa, and 11 (11%) were categorized as pathological stage IIIb. The overall actuarial 3-year survival rate was 27%. Postpneumonectomy complications occurred in 20 patients. Operative mortality occurred only in 8 pathological stage IIIa male patients (7.6%). No significant differences in operative mortality were noted for the following criteria: age, sex, side of resection, pathological stage, histologic classification, preoperative forced expiratory volume in 1 second (FEV1) of 2.0 L or less, and predicted postoperative FEV1 of 1.0 L or less. Of the surviving 97 patients, 3 patients were lost during follow-up, 13 patients (13.8%) died due to pneumonia and/or respiratory failure, and 40 patients (42.6%) died due to distant metastases, with bone as the most common metastatic site, during the mean follow-up time of 39 months. Pathological stage I and stage II patients showed actuarial 3-year survival rates, of 60.0% and 31.3% respectively. The survival rates of stage I and stage II patients were higher than for stage IIIa patients.

AB - Between 1982 and 1992, 105 patients with non-small cell lung cancer underwent pneumonectomy and mediastinal node dissection. Thirteen patients (12%) were categorized as pathological stage I, 18 (17%) were categorized as pathological stage II, 63 (60%) were categorized as pathological stage IIIa, and 11 (11%) were categorized as pathological stage IIIb. The overall actuarial 3-year survival rate was 27%. Postpneumonectomy complications occurred in 20 patients. Operative mortality occurred only in 8 pathological stage IIIa male patients (7.6%). No significant differences in operative mortality were noted for the following criteria: age, sex, side of resection, pathological stage, histologic classification, preoperative forced expiratory volume in 1 second (FEV1) of 2.0 L or less, and predicted postoperative FEV1 of 1.0 L or less. Of the surviving 97 patients, 3 patients were lost during follow-up, 13 patients (13.8%) died due to pneumonia and/or respiratory failure, and 40 patients (42.6%) died due to distant metastases, with bone as the most common metastatic site, during the mean follow-up time of 39 months. Pathological stage I and stage II patients showed actuarial 3-year survival rates, of 60.0% and 31.3% respectively. The survival rates of stage I and stage II patients were higher than for stage IIIa patients.

KW - carcinoma non-small-cell lung

KW - lung neoplasms-surgery

KW - pneumonectomy

KW - survival rate

UR - http://www.scopus.com/inward/record.url?scp=0029065878&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029065878&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0029065878

VL - 29

SP - 19

EP - 24

JO - Radiology and Oncology

JF - Radiology and Oncology

SN - 1318-2099

IS - 1

ER -